Literature DB >> 10980885

Natural history of hypertrophic cardiomyopathy.

P M Elliott1.   

Abstract

Hypertrophic cardiomyopathy is a disease of the cardiac sarcomere and is the most common inherited cardiovascular disorder affecting up to 1 in 500 people in the general population. The disease is typified by variable clinical penetrance and heterogeneous clinical expression, resulting in a wide range of clinical manifestations. Most patients have few if any symptoms and a relatively benign clinical course. A minority are at risk of serious complications including ventricular arrhythmia, sudden death, thromboembolism, congestive cardiac failure, heart block, and infective endocarditis. This article reviews the natural history of the disease, with particular emphasis on lessons learned from recent genetic studies.

Entities:  

Mesh:

Year:  2000        PMID: 10980885     DOI: 10.1007/s11886-000-0011-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  49 in total

1.  Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene.

Authors:  P M Elliott; L D'Cruz; W J McKenna
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

2.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

3.  Familial cardiomegaly.

Authors:  W EVANS
Journal:  Br Heart J       Date:  1949-01

4.  Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant?

Authors:  F Romeo; F Pelliccia; R Cristofani; E Martuscelli; A Reale
Journal:  Eur Heart J       Date:  1990-03       Impact factor: 29.983

5.  Natural history of hypertrophic cardiomyopathy in the elderly.

Authors:  W P Fay; C P Taliercio; D M Ilstrup; A J Tajik; B J Gersh
Journal:  J Am Coll Cardiol       Date:  1990-10       Impact factor: 24.094

6.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

7.  Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

Authors:  C R Cannan; G S Reeder; K R Bailey; L J Melton; B J Gersh
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

8.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

9.  Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy.

Authors:  S Jones; P M Elliott; S Sharma; W J McKenna; B J Whipp
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

10.  Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

Authors:  P Spirito; C Rapezzi; P Bellone; S Betocchi; C Autore; M R Conte; G P Bezante; P Bruzzi
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.